Immune checkpoint inhibitors combined with tyrosine kinase inhibitors or immunotherapy for treatment-naïve metastatic clear-cell renal cell carcinoma-A network meta-analysis. Focus on cabozantinib combined with nivolumab

• Main Authors: Maciej Niewada (Author), Tomasz Macioch (Author), Magdalena Konarska (Author), Aneta Mela (Author), Adam Goszczyński (Author), Bogusława Przekopińska (Author), Karolina Rajkiewicz (Author), Piotr Wysocki (Author), Maciej Krzakowski (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: The combination of immunotherapy and targeted therapy is currently marking a new era in the treatment of renal cancer. The latest clinical guidelines recommend the use of drug combinations for the first-line treatment of advanced renal cancer. The aim of this review is to compare the e...